Barbara Friedland is an associate in the Population Council’s HIV and AIDS program based in New York City. Since joining the Council in 1996, she has been involved in both clinical and behavioral research, primarily focused on HIV prevention. Friedland coordinated several international clinical trials of the Council’s first candidate microbicide, Carraguard®, and is currently study manager for the first in-human study of the Council’s next-generation ARV-based microbicide, PC-1005. Friedland has also been active in the development and testing of educational materials related to clinical trials and service delivery. She produced four multi-language educational videos, including Hope Against HIV: Microbicides Trials in Your Community and The Rectal Revolution Is Here: An Introduction to Rectal Microbicide Clinical Trials to explain microbicide clinical trials to potential research participants and their communities, and PEP: Preventing HIV after Exposure for use in educating South African communities about post-exposure prophylaxis to prevent HIV infection.
Friedland’s research also includes efforts to improve informed consent in clinical trials and service delivery. Most recently, she led a study of the informed consent process for male circumcision services as they were being expanded in Swaziland and Zambia.
Friedland has an MPH from Hunter College of the City University of New York and a master’s of music in piano performance from the Mason Gross School of the Arts, Rutgers University.